Dr Mikael Sodergren is Senior Clinical Lecturer at Imperial College London and Consultant Hepatobiliary & Pancreatic Surgeon at Imperial College Healthcare NHS Trust. He is also the Chief Medical Officer of Curaleaf International, where he leads the clinical and pre-clinical cannabinoid research programme. Dr Sodergren specialises in complex pancreas, liver and gallbladder surgeries including keyhole and robotic surgeries. Dr Sodergren has published over 150 peer-reviewed articles, in addition to several book chapters and he is on the editorial board of 3 medical journals. He has a diverse portfolio of research and is the inventor of an internationally patented surgical device. He leads the Medical Cannabis Research Group – a research programme which evaluates and develops novel therapies targeting the endocannabinoid system through a framework of in vitro, in vivo, and clinical translational activities.
